Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,914 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of Abrupt Switch to Bevacizumab of Patients Undergoing Aflibercept Intravitreal Injections for Neovascular Age-Related Macular Degeneration in a Tertiary Center in Lombardy, Italy: A Real-Life Retrospective Analysis.
Randazzo A, Raimondi R, Fossati G, Romano M, Sorrentino T, Castellani C, Rossi C, Cancian G, Vinciguerra P. Randazzo A, et al. Among authors: rossi c. J Ophthalmol. 2021 Sep 11;2021:7940297. doi: 10.1155/2021/7940297. eCollection 2021. J Ophthalmol. 2021. PMID: 34676113 Free PMC article.
Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration.
Borrelli E, Coco G, Pellegrini M, Mura M, Ciarmatori N, Scorcia V, Carnevali A, Lucisano A, Borselli M, Rossi C, Reibaldi M, Ricardi F, Vagge A, Nicolò M, Forte P, Cartabellotta A, Hasanreisoğlu M, Kesim C, Demirel S, Yanık Ö, Bernabei F, Rothschild PR, Farrant S, Giannaccare G. Borrelli E, et al. Among authors: rossi c. Ophthalmol Ther. 2024 Nov;13(11):2855-2868. doi: 10.1007/s40123-024-01030-w. Epub 2024 Sep 13. Ophthalmol Ther. 2024. PMID: 39271642 Free PMC article.
Outcomes of low-level light therapy before and after cataract surgery for the prophylaxis of postoperative dry eye: a prospective randomised double-masked controlled clinical trial.
Giannaccare G, Rossi C, Borselli M, Carnovale Scalzo G, Scalia G, Pietropaolo R, Fratto B, Pellegrini M, Yu AC, Scorcia V. Giannaccare G, et al. Among authors: rossi c. Br J Ophthalmol. 2024 Jul 23;108(8):1172-1176. doi: 10.1136/bjo-2023-323920. Br J Ophthalmol. 2024. PMID: 37890879 Clinical Trial.
Outcomes of the addition of oral administration of curcumin-phospholipid to hyaluronic acid-based tear substitute for the treatment of dry eye disease.
Borselli M, Ferrari FF, Bianchi P, Rossi C, Scalzo GC, Mangialavori D, Scorcia V, Giannaccare G. Borselli M, et al. Among authors: rossi c. Front Ophthalmol (Lausanne). 2023 Oct 5;3:1236525. doi: 10.3389/fopht.2023.1236525. eCollection 2023. Front Ophthalmol (Lausanne). 2023. PMID: 38983042 Free PMC article.
2,914 results